Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1305Other hematologic neoplasm 898Breast 647Plasma cell 367Myeloid 261Sarcoma 210Dermatologic 194CNS 179Gastrointestinal 135Gynecologic 126Genitourinary 117Thoracic 101Classical hematology 94Other solid neoplasm 72Head & Neck 48Tumor-Agnostic 28Other neoplasm 13Endocrine 6NET 4Other 2

Conditions

Obesity 1Mucositis 1Leukemia 1Breast Neoplasms 1Body Weight 1

Interventions

Exercise 28Metformin 24Surveys and Questionnaires 19Radiotherapy 14Methods 14Early Intervention, Educational 13Counseling 13Educational Status 12naloxegol 10Standard of Care 10Tirzepatide 9Nutrition Assessment 9Diet Therapy 9Cisplatin 9Resistance Training 8Psychiatric Rehabilitation 8Diet 8Therapeutics 7Interviews as Topic 7alvimopan 6Liraglutide 6Fibroblast Growth Factor 7 6Caloric Restriction 6semaglutide 5Radiation 5Low-Level Light Therapy 5Injections 5Exenatide 5Diet, Mediterranean 5Dexamethasone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Cyclophosphamide × Other × Clear all
NCT01085617 2025-03-30

UKALL14

University College, London

Completed
OtherOther hematologic neoplasm

Leukemia, Mucositis

NCT01537029 2018-08-22

Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide

Texas Tech University Health Sciences Center

Phase 4 Completed
15 enrolled 6 charts
BreastOther

Body Weight, Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡